Get Yahoo Finance Tech, a weekly newsletter featuring our original content on the industry, sent directly to your inbox every Wednesday by 4 p.m. ET. Subscribe
The hottest back to school tech deals for 2019: The school year is quickly approaching and that means parents across the country are hastily searching for the best deals to ensure that their kids have all of the latest laptops, smartphones, tablets and headphones they need to make it through another 10 months of classes.
Luckily for you, there’s still plenty of savings to be found on all of your back-to-school tech needs. So, while your kid might be bummed that their summer is almost over, at least you’ll be excited that you’re saving some cash. Read more
After sliding along with the rest of the stock market on Friday, shares of lithium mining stock Lithium Americas (NYSE: LAC) are rebounding in a big way on Monday -- up 13.6% as of 12:15 p.m. ET. You can thank the friendly analysts at National Bank Financial for that. No sooner had Lithium Americas finished its Friday slide than an analyst at the Canadian investment bank stepped in and reiterated an outperform recommendation on the stock.
Wall Street has known its share of legends, but few of them have made as big a splash as “the Man Who Broke the Bank of England.” That nickname belongs to George Soros who earned the tag after famously betting against the British Pound in 1992; following the Black Wednesday crash, the hedge fund manager pocketed a $1 billion in a single day. This is the stuff that Wall Street legends are made of. By then Soros was already incredibly successful and in the midst of steering his Quantum Fund to dec
-- in which its stock shed 3.6%, shares of semiconductors star Nvidia (NASDAQ: NVDA) are bouncing back Monday morning, up 2.8% as of 11 a.m. ET. The reason: I suspect investors are shrugging off last week's bad coronavirus news and focusing on some good Nvidia news that got overlooked. Specifically, I mean the news that on Friday analysts at investment bank Bank of America doubled down on their buy rating on Nvidia stock.
The technology powering virtual reality (VR) experiences has significantly improved in recent years. This technology is powering real-world applications like virtual walkthroughs of buildings and products still on the drawing board, or collaborations with colleagues in a virtual meeting room. Facebook has made a big splash into this new "metaverse" by changing its name to Meta Platforms (NASDAQ: FB), but that's not the only way to play this trend as an investor.
Shares of Apple (NASDAQ: AAPL) stock closed up 2.2% on Monday following a holiday weekend that featured new commentary on the company and its products from Bloomberg. Last week, if you recall, Apple shares got a boost from reports that the company is planning to build an electric car with autonomous driving capability and also has an augmented reality headset in the works -- one that will be powerful enough to work as a stand-alone device. Well, over the weekend, Bloomberg expanded on these reports, adding that Apple is also working to develop augmented reality (AR) glasses (i.e., something different from the headset) and predicting that consumers (and investors) might get their first look at the AR headset as early as June 2022 if the company decides to unveil it at Apple's planned Worldwide Developers Conference next June.
Words have power -- as investors discovered to their dismay last week. News of the new omicron variant of COVID-19 shocked the stock market, sending shares of cruise line stocks Royal Caribbean (NYSE: RCL), Carnival (NYSE: CCL) (NYSE: CUK), and Norwegian Cruise Line Holdings (NYSE: NCLH) tumbling 10% and more in Friday trading.
(Bloomberg) -- The Chinese businessman had walked out of a bank in Kinshasa with 13,624 hundred-dollar bills, 10,001 fifties and 43,000 smaller U.S. notes, despite explicit instructions to prevent it from happening.Most Read from BloombergChina Cash Flowed Through Congo Bank to Former President’s Cronies‘Pension Poachers’ Are Targeting America’s Elderly Veterans“The account has finally been emptied,” Yvon Douhore, head of an in-house audit team in the capital of the Democratic Republic of Congo,
Although it's been a dud of a performer in 2021, telehealth platform Teladoc Health (NYSE: TDOC) is a holding I fully expect to deliver 10X (or greater) returns by the time I'm ready to enjoy retirement. While some folks would opine that Teladoc was lucky to be in the right place at the right time when the pandemic struck, I'd contend that they're not looking at the bigger picture. For instance, in the six years leading up to the pandemic, Teladoc's average annual sales grew by 74%.
An investment arm of Wichita-based Koch Industries Inc. has put $100 million behind a company working on a new way to extract lithium. Koch Strategic Platforms (KSP) will make the investment in Canada-based Standard Lithium through a direct private placement in the company valued at more than 13.4 million shares. The deal also allows for potential collaboration with other Koch subsidiaries, including Koch Engineered Solutions and Koch Minerals & Trading.
(Bloomberg) -- Merck & Co. shares have wiped out their gains for 2021 and are on track for their worst month in 12 years amid weakening data for its Covid-19 pill.Most Read from BloombergChina Cash Flowed Through Congo Bank to Former President’s Cronies‘Pension Poachers’ Are Targeting America’s Elderly VeteransReliving the New York Subway Map DebateThe stock was the biggest decliner in the S&P 500 on Monday, falling 5.4% and hitting a two-month low ahead of a U.S. Food and Drug Administration ad
Adagio Therapeutics Inc. is riding high after the company said its experimental antibody is likely to be just as effective against the omicron variant of the coronavirus as it is against previous variants. The antibody, a drug called ADG20, affords protection for up to one year, according to the firm.
Hedge-fund luminary Bill Ackman over the weekend says the new omicron variant of the coronavirus that causes COVID-19 could be bullish for stocks if it results in mild to moderate symptoms for those who contract it.